Top Tweets for #THYCSM
#ClinicalTrial EA3231, led by @LovaSunMD of @PennCancer, is testing #TargetedTherapy approaches for patients with #ThyroidCancer that has worsened during or after treatment. For more information: https://t.co/4276H54qPr #thycsm
Therapeutically Targetable Mutational Landscape of Anaplastic Thyroid Cancer.
Read the full article. https://t.co/w77v0QKVpH
#thycsm
@MayoClinic Integrated Care Enables Treatment for Rare, Complex Cancer
#thycsm #oncology
https://t.co/sSckzHV39g
Our team recently attended the British Thyroid Association Annual Meeting, where we presented new research on radioiodine-refractory differentiated thyroid cancer (RAI-R DTC).
#thycsm
Circulating Tumor DNA as a Biomarker for Disease
Surveillance in Anaplastic #ThyroidCancer.
Read the full article. https://t.co/PWLrKXNJzK
#thycsm
An updated analysis on larotrectinib for patients with TRK fusion thyroid carcinoma showed compelling data on the agent’s efficacy and safety, including a high and durable response rate and a manageable safety profile. #thycsm #ASCO25 | @KimmelCancerCtr
https://t.co/pZ2xfTG2LJ
WATCH: Nicole A. Cipriani, MD, explores the clinical relevance of the BRAF p.V600E mutation in papillary thyroid carcinoma and its potential role in guiding treatment decisions. #thycsm | @nicolecipriani
https://t.co/unnKX4mLBN
An Italian study (NCT04031339) has found that patients with papillary thyroid carcinoma smaller than 1 cm typically experience more favorable outcomes compared with patients whose tumors are larger, particularly 1 year after surgery. #thycsm
https://t.co/vYoHHMI5KH
In a video, Francis P. Worden, MD, offers key takeaways for oncologists treating patients with radioidine-refractory differentiated thyroid cancer. #thycsm | @UMRogelCancer
https://t.co/MY624Km8vq
WATCH: Francis P. Worden, MD, discusses his key takeaways for other oncologists treating patients with radioidine-refractory differentiated thyroid cancer. #thycsm | @UMRogelCancer
@umichmedicine
https://t.co/fF6AQRvgcJ
WATCH: Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management. #thycsm | @BaptistHealthSF
https://t.co/uio5vd03jm
Learn about signs, symptoms and warning signs of #thyroidcancer from Jochen Lorch, MD, medical director of our Thyroid Cancer Program at @LurieCancer @NorthwesternMed. #thycsm
A medical oncologist weighs in on the thyroid cancer symptoms to never ignore.
Lori J. Wirth, discussed recent analyses that have developed a better understanding of the outcomes with lenvatinib in differentiated thyroid cancer. #thycsm | @MassGeneralMDs
https://t.co/fnzcVW6e14
In this video, Francis P. Worden, MD, discusses how the effectiveness of lenvatinib in this real-world setting compares with results from other clinical trials. #thycsm
https://t.co/NSpkYm60Nb
Atezolizumab + targeted therapy demonstrated longer median overall survival compared with historic controls in patients with anaplastic thyroid cancer, according to findings from a phase 2 study. #thycsm
https://t.co/YO6FDgukoC
Nivolumab Plus Ipilimumab in Aggressive Thyroid Carcinoma https://t.co/C12DQuvFhy #thycsm #thyroidcancer #oncology #immunotherapy
The FDA granted traditional approval to selpercatinib for adult & pediatric patients aged 2 years & older with advanced or metastatic medullary thyroid cancer with a RET mutation, as detected by an FDA-approved test, who require systemic therapy. #thycsm
https://t.co/YXp7WWT272
Geoffrey D. Young, MD, PhD, FACS, discussed the many advances in thyroid cancer management and treatment, highlighting what a community oncologist should be aware of. #thycsm | @BaptistHealthSF @BHCancerCare @MiamiCancerInst
https://t.co/RFsTcfb7SW
Long-Term Look at Selpercatinib in RET-Activated Thyroid Cancer https://t.co/xlmbAOf7T1 #thycsm #thyroidcancer #oncology
According to Lori J. Wirth, MD, one crucial shift of late has been with the growing ability to avoid over diagnosing clinically insignificant thyroid cancers. #THYCSM | @MGHCancerCenter
https://t.co/qsw9RuPGnp
Last Seen Hashtags on Sotwe
incest mom and son
Seen from Thailand
omorashi
Seen from United States
Presenoldeb
Seen from United States
çorumgay
Seen from Turkey
sissy
Seen from Belgium
hijab suck() +filter:native_video
Seen from Germany
เย็ดเมียชาวบ้าน
Seen from Thailand
teenageee
Seen from United States
抓龙筋
Seen from United States
adanapasif
Seen from Turkey
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.6M followers